Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors
27 juin 2024 08h49 HE
|
Spherix Global Insights
Exton, Pennsylvania, June 27, 2024 (GLOBE NEWSWIRE) -- Prior to 2023, there was no treatment for GA, a progressive form of dry age-related macular degeneration that results in blindness. That...
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Continued Unmet Needs and Track New Launches
26 juin 2024 04h00 HE
|
Spherix Global Insights
EXTON, PA, June 26, 2024 (GLOBE NEWSWIRE) -- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disorder in which red blood cells prematurely break apart, a process known as hemolysis....
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
25 juin 2024 09h00 HE
|
Qure.ai Technologies Limited
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI.
Ophthalmologists Favor Genentech’s Vabysmo and Regeneron’s Eylea HD for Diabetic Macular Edema Treatment Despite Payer Constraints
24 juin 2024 09h27 HE
|
Spherix Global Insights
EXTON, PA., June 20, 2024, June 24, 2024 (GLOBE NEWSWIRE) -- The treatment landscape for Diabetic Macular Edema (DME) continues to evolve, with innovative therapies and emerging data significantly...
Afamelanotide in fair-skinned Parkinson’s patients
17 juin 2024 20h39 HE
|
Clinuvel Pharmaceuticals Limited
CLINUVEL has launch a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease in fair-skinned patients.
Clinical Trials Market Forecast: USD 174.3 Billion by 2033, Driven by 6.8% CAGR | Dimension Market Research
17 juin 2024 12h19 HE
|
Dimension Market Research
New York, June 17, 2024 (GLOBE NEWSWIRE) -- Overview The Global Clinical Trials Market size is expected to reach a market value of USD 96.8 billion and it is further anticipated to reach a market...
US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, Projecting Rapid Adoption Post-Launch
12 juin 2024 12h18 HE
|
Spherix Global Insights
EXTON, PA, June 12, 2024 (GLOBE NEWSWIRE) -- Despite being the second IL-23 inhibitor to enter the market, AbbVie’s Skyrizi (risankizumab) is expected to have a substantial impact on ulcerative...
Insulin Delivery Devices Market Is Expected To Reach a Revenue Of USD 75.4 Bn By 2033, At 8.8% CAGR | Dimension Market Research
11 juin 2024 11h46 HE
|
Dimension Market Research
New York, June 11, 2024 (GLOBE NEWSWIRE) -- The Global Insulin Delivery Devices Market size is expected to reach USD 35.2 billion by 2024 and is further anticipated to reach USD 75.4 billion by 2033...
Biopharma Plastics Market Set for Strong Growth Trajectory, Targeting USD 18,130.3 Million by 2033 | Dimension Market Research
11 juin 2024 11h08 HE
|
Dimension Market Research
New York, June 11, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biopharma Plastics Market reached USD 5,695.3 million in 2023 and is further anticipated to reach USD 18,130.3 million by 2033...
Biopharmaceutical Market to Reach USD 1,829.2 Billion by 2033, Growing at 15.4% CAGR | Dimension Market Research
10 juin 2024 10h12 HE
|
Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biopharmaceutical Market size reached USD 436.7 billion in 2023 and is further anticipated to reach USD 1,829.2 billion by 2033...